Hypertrophic Cardiomyopathy After a Single Dose of Dexamethasone in a Preterm Infant.
Pediatr Neonatol
; 56(4): 268-70, 2015 Aug.
Article
em En
| MEDLINE
| ID: mdl-23639746
Dexamethasone is widely used in preterm infants with severe pulmonary disease. Hypertrophic cardiomyopathy (HCM) is a transient side effect observed after multiple doses of dexamethasone. We report a preterm infant with myocardial hypertrophy after a single dose of dexamethasone (0.5 mg/kg) used to treat laryngeal edema secondary to prolonged intubation. A benign course was observed without left ventricular outflow tract obstruction and with recovery within 4 weeks. Myocardial effects of dexamethasone may be independent of dose and duration of treatment. The risk/benefit ratio must be carefully considered before using even a single dose of dexamethasone in preterm infants.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Cardiomiopatia Hipertrófica
/
Recém-Nascido Prematuro
/
Dexametasona
/
Glucocorticoides
Tipo de estudo:
Diagnostic_studies
Limite:
Female
/
Humans
/
Infant
/
Newborn
Idioma:
En
Ano de publicação:
2015
Tipo de documento:
Article